The advent of anti-vascular endothelial growth factor (VEGF) designed for intraocular injection has revolutionised the treatment of neovascular age-related macular degeneration (nAMD), the leading ...
Please provide your email address to receive an email when new articles are posted on . It has been more than 10 years since the introduction of anti-VEGF therapy for neovascular age-related macular ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results